Part B: Supplementary Information Sheet (SIS) |
FR Recognition List Number
|
028
|
Date of Entry 03/16/2012
|
FR Recognition Number
|
12-232
|
Standard | |
NEMA MS 4-2010 Acoustic Noise Measurement Procedure for Diagnosing Magnetic Resonance Imaging Devices |
|
Scope/AbstractThe purpose of this NEMA Standards Publication is to provide methods to determine the acoustic noise level of an MR system. Two measurement procedures are defined, Maximum Gradient Acoustic Noise (MGAN) and Maximum Clinical Acoustic Noise (MCAN).
This procedure has been designed for measuring peak sound pressure levels (SPL) up to 140 dB. Above 140 dB, the use of more sophisticated equipment and methods may be required. |
|
Extent of Recognition
|
Rationale for Recognition
This standard is relevant to medical devices and is recognized on its scientific and technical merit and/or because it supports existing regulatory policies. |
|
Transition Period
FDA recognition of NEMA MS 4-2010 [Rec# 12-232] will be superseded by recognition of NEMA MS 4-2023 [Rec# 12-354]. FDA will accept declarations of conformity, in support of premarket submissions, to [Rec# 12-232] until July 05, 2026. After this transition period, declarations of conformity to [Rec# 12-232] will not be accepted. |
|
Public Law, CFR Citation(s) and Procode(s)*
Regulation Number |
Device Name |
Device Class |
Product Code |
§892.1000 |
System, Nuclear Magnetic Resonance Imaging
|
Class 2
|
LNH
|
§892.1000 |
System, Nuclear Magnetic Resonance Spectroscopic
|
Class 2
|
LNI
|
§892.1000 |
Coil, Magnetic Resonance, Specialty
|
Class 2
|
MOS
|
|
Relevant FDA Guidance and/or Supportive Publications*
Guidance for Industry
Guidance for the Submission of Premarket Notifications for Magnetic Resonance Diagnostic Devices. Document issued on: November 14, 1998
Appropriate Use of Voluntary Consensus Standards in Premarket Submissions for Medical Devices - Guidance for Industry and Food and Drug Administration Staff, issued September 2018. |
|
FDA Technical Contact
|
Standards Development Organization
|
FDA Specialty Task Group (STG)
|
*These are provided as examples and others may be applicable. |